Prognostic significance of grading in lung adenocarcinoma.
about
Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyDifferential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylationPersonalized identification of altered pathways in cancer using accumulated normal tissue data.FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer PrognosisLung Cancer Pathological Image Analysis Using a Hidden Potts Model.A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesotheliomaPrognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I diseaseRisk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patientsImplementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.IMP3 can predict aggressive behaviour of lung adenocarcinoma.Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosisComprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes.Negative regulation of Bmi-1 by AMPK and implication in cancer progression.High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology.Clinical and pathologic prognostic factors that are influential in the survival and prognosis of lung adenocarcinomas and invasive predominant subtypes.Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients.Histological subtypes of solitary pulmonary nodules of adenocarcinoma and their clinical relevance.Factors associated with early progression of non-small-cell lung cancer treated by epidermal growth factor receptor tyrosine-kinase inhibitors.Pathologic heterogeneity of lung adenocarcinomas: A novel pathologic index predicts survival.Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT imagesProgenitor stem cell marker expression by pulmonary carcinomas.Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma.LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells.Ex vivo multiplex profiling of protein tyrosine kinase activities in early stages of human lung adenocarcinoma.Tumor cell proliferation, proliferative index and mitotic count in lung cancer.Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas.Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma.Histopathology of lung adenocarcinoma based on new IASLC/ATS/ERS classification: prognostic stratification with functional and metabolic imaging biomarkers.Prognostic significance of histologic subtype in pStage I lung adenocarcinoma.Classification and regression tree analysis of patients with non-small-cell lung cancer treated with gefitinib after chemotherapy.Nuclear grade based on transbronchial cytology is an independent prognostic factor in patients with advanced, unresectable non-small cell lung cancer.
P2860
Q27009370-53BF24E4-D28D-427F-B353-08200D2BC0ABQ28655985-F3DCBED0-6EF0-4337-9668-4CACD6F4E2E8Q28730029-A8D42143-AD04-4FE1-B8F7-6579893639EBQ30366103-53FBE680-B2AC-4040-BA3D-0EDDEE65FC79Q33724626-321E4553-E71F-47E8-88EC-68E11F766A78Q33762059-173A2114-3217-42AA-83BE-A8A9638EC7C8Q33772555-ACDBC7D5-BFA0-48A3-858A-7D310E449A41Q33773524-C5151E71-9394-4015-BB6C-9488ED864D34Q33840661-23AC2CBE-0524-4AB6-97F6-B8C9A11FA44BQ34181641-D9A151F6-17FE-4242-B5F5-C8DF1625FFC2Q34208219-48B323F9-62F5-410F-810E-5686C2B0F6BDQ34404229-1D76426E-2B89-4CB6-9192-C35D48D733B8Q35219157-E4B9BE31-69EE-4C57-8AC5-01B38DA35DF9Q35245367-EF3B5F3A-9B60-4042-B9A1-EC70D58FFA6AQ35954585-97CDBEB6-5F54-4113-AED5-8ABBE946A9A5Q36013991-199537D6-0297-4DA2-8CE5-32E88D5B10D4Q36498167-D1CF923B-4306-4E63-B67C-717A8D6D3C00Q36532787-4312D13C-23A4-4D61-A913-09225ADABFADQ36726239-AB53EAD8-FB65-4123-8C6E-004D9C7DDE53Q36905874-C35FE5B4-D049-42C7-8B68-562347CC4B85Q36952692-1D968B32-7952-47A2-804C-6BDF0AFF6EB6Q37131209-4B4591B5-F574-47BC-919C-00DAEA6F503EQ37176131-2D883DD6-4EAF-45B1-AD4F-0146F345A848Q37457343-036A02C6-07E6-4E91-8C50-F67C2095A755Q37595242-C7716EC6-D58B-4E34-BF18-8177A5BF39D1Q37688529-D4803AB5-1C96-4781-9FFA-BF361CAE5D80Q37702306-A978D243-D477-400E-9705-E95EC780B730Q38417341-1A0A12A2-8E4F-43EC-B0F7-071CCDF16FDCQ38732479-1DB47AC9-0B7E-4F2D-B9B1-7EF2A9CA6CDEQ38841094-EC72EEDE-B351-4EC3-84C8-E5648B6B52A4Q40409282-0DA9BCE5-0D29-4664-859C-845FEBAB3CF9Q41579730-2D8C96AA-CABF-442D-A6E9-52ABA220CE66Q41822673-AAFF505C-E00C-4A3F-BAE6-98697362D4D7Q42372532-3F2AD2A8-F396-465D-9E1D-8A5B7B68253AQ43848444-AE5C4137-D06A-4B2F-B38F-A5A3046A3A1FQ45943784-244D42D9-05C4-4C18-AC6B-1F6A976C7411Q46461279-2F1E4FA7-2AEE-4BE6-A625-378C82D98596Q47912811-62EF2D90-BCBB-4DED-A33F-FF61974E254EQ50050455-06F204B5-CB3C-4040-A8D8-7F82FFDEEBFEQ51525251-A96CF5E1-DB9B-408F-8E02-3C22C0EFFA15
P2860
Prognostic significance of grading in lung adenocarcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Prognostic significance of grading in lung adenocarcinoma.
@ast
Prognostic significance of grading in lung adenocarcinoma.
@en
type
label
Prognostic significance of grading in lung adenocarcinoma.
@ast
Prognostic significance of grading in lung adenocarcinoma.
@en
prefLabel
Prognostic significance of grading in lung adenocarcinoma.
@ast
Prognostic significance of grading in lung adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
Prognostic significance of grading in lung adenocarcinoma.
@en
P2093
Beow Y Yeap
Justine A Barletta
Lucian R Chirieac
P2860
P304
P356
10.1002/CNCR.24831
P407
P577
2010-02-01T00:00:00Z